Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT05480189
What this trial is testing

Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study

Who this might be right for
Histologically Confirmed Breast Cancer ,Diagnosis of Bone Metastasis
Zhejiang Cancer Hospital 1,000
Early research (Phase 1)Looking for participantsNCT05372640
What this trial is testing

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma+5 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Ended earlyNCT03952325
What this trial is testing

Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC

Who this might be right for
Breast Cancer
Odonate Therapeutics, Inc. 294
Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738341
What this trial is testing

GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)
Eddingpharm (Zhuhai) Co., Ltd. 270
Not applicableStudy completedNCT01282931
What this trial is testing

Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Health Outcomes Solutions 200
Early research (Phase 1)Study completedNCT02416466
What this trial is testing

CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases

Who this might be right for
Liver Metastases
Roger Williams Medical Center 8
Not applicableActive Not RecruitingNCT01996046
What this trial is testing

FDG PET/CT in Breast Cancer Bone Mets

Who this might be right for
Estrogen Receptor Positive Breast CancerBone Metastases
University of Pennsylvania 75
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableLooking for participantsNCT06896162
What this trial is testing

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Who this might be right for
Solid Tumor MalignanciesMetastatic CancerBreast Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 500
Not applicableUnknownNCT06135194
What this trial is testing

Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib

Who this might be right for
Breast Cancer
Beijing 302 Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586866
What this trial is testing

JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases

Who this might be right for
Triple Negative Breast Cancer (TNBC)Brain Metastasases
JenKem Technology Co., Ltd. 25
Not applicableUnknownNCT01224873
What this trial is testing

Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET

Who this might be right for
Breast Cancer
Rigshospitalet, Denmark 110
Post-approval studies (Phase 4)Study completedNCT01907880
What this trial is testing

The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 74
Early research (Phase 1)Active Not RecruitingNCT05143970
What this trial is testing

First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more
Institut Paoli-Calmettes 27
Not applicableLooking for participantsNCT07252986
What this trial is testing

Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence

Who this might be right for
BreastBreast CancerPathology
Second Affiliated Hospital, Zhejiang University, School of Medicine 2,000
Testing effectiveness (Phase 2)Study completedNCT01738438
What this trial is testing

Cabozantinib for Metastatic Triple Negative BrCa

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 35
Testing effectiveness (Phase 2)UnknownNCT04061408
What this trial is testing

FSRT in Breast Cancer Patients With Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Fudan University 170
Early research (Phase 1)Study completedNCT01471847
What this trial is testing

A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab

Who this might be right for
Locally Advance Breast Cancer (LABC)Metastatic Breast Cancer (MBC)
Novartis Pharmaceuticals 5
Not applicableNot Yet RecruitingNCT07521826
What this trial is testing

Exercise Training in Women With Metastatic Breast Cancer

Who this might be right for
CancerMetastases
State University of Londrina 78
Next Page